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Introduction
Polarity, an essential property of eukaryotic cells, allows yeast 
cells to bud and mate, epithelial cells to form apical and baso-
lateral surfaces, neurons to form synapses, fi  broblasts to heal 
wounds, and leukocytes to crawl to sites of infection. These be-
haviors require the orientation of polarity toward external cues 
that are detected by cell surface receptors, which trigger a com-
plex interplay between Rho GTPases and the actin and micro-
tubule cytoskeletons. At the cell’s leading edge, this interplay 
often depends on phosphatidylinositol-3,4,5-tris-phosphate 
(PIP3), a membrane lipid, and creates positive feedback loops 
(Weiner et al., 2000; Devreotes and Janetopoulos, 2003).
In differentiated HL60 (dHL60) cells, a neutrophil-like cell 
line, polarity is mediated by two divergent and competing sets of 
signals, both triggered by a single species of receptor (Xu et al., 
2003). A tripeptide chemoattractant, f-Met-Leu-Phe (fMLP), 
triggers frontness (protrusive fi  lamentous actin [F-actin] in pseu-
dopods) by stimulating receptor-mediated activation of a trimeric 
G protein, Gi, which in turn initiates a signaling cascade in which 
positive feedback loops linking PIP3, Rac, and F-actin create ro-
bust pseudopods (Niggli, 2000; Wang et al., 2002; Weiner et al., 
2002). fMLP stimulates backness (contractile actomyosin) by 
inducing the receptor-dependent activation of G12 and G13, which 
promote the activity of RhoA, a Rho-dependent kinase (p160– Rho-
associated coil-containing protein kinase [ROCK]), and myosin II 
(Xu et al., 2003). In a polarized cell, RhoA-dependent backness 
confi  nes frontness to pseudopods (Xu et al., 2003), whereas 
Rac-dependent frontness reciprocally constrains backness to the 
cell’s trailing edge (Wong et al., 2006).
The ability of frontness and backness to inhibit one another 
locally helps to explain the segregation of these two responses 
in a polarized cell. However, it does not explain how uniformly 
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hemoattractants like f-Met-Leu-Phe (fMLP) induce 
neutrophils to polarize by triggering divergent 
signals that promote the formation of protrusive 
ﬁ  lamentous actin (F-actin; frontness) and RhoA-  dependent 
actomyosin contraction (backness). Frontness locally in-
hibits backness and vice versa. In neutrophil-like HL60 
cells, blocking phosphatidylinositol-3,4,5-tris-phosphate 
(PIP3) accumulation with selective inhibitors of PIP3 
  synthesis completely prevents fMLP from activating a PIP3-
dependent kinase and Cdc42 but not from stimulating 
F-actin accumulation. PIP3-deﬁ  cient cells show reduced 
fMLP-  dependent Rac activity and unstable pseudopods, 
which is consistent with the established role of PIP3 as 
a mediator of positive feedback pathways that augment 
Rac activation at the front. Surprisingly, such cells also 
show reduced RhoA activation and RhoA-dependent 
contraction at the trailing edge, leading to the formation 
of multiple lateral pseudopods. Cdc42 mediates PIP3’s 
positive effect on RhoA activity. Thus, PIP3 and Cdc42 
maintain stable polarity with a single front and a single 
back not only by strengthening pseudopods but also, at 
longer range, by promoting RhoA-dependent actomyosin 
contraction at the trailing edge.
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applied fMLP elicits the formation of a single stable front rather 
than many in the absence of any spatial cue.  Formation of a  single 
stable front is similarly elicited by applying a uniform stimulus to 
many other cells: yeast, neurons, and Dictyostelium discoideum 
amoebae form one shmoo tip (Wedlich-Soldner et al., 2004), one 
axon (de Anda et al., 2005), or one pseudopod (Weiner et al., 
2000; Devreotes and   Janetopoulos, 2003), respectively.
In this study, we report that fMLP cannot elicit the forma-
tion of a single stable pseudopod in dHL60 cells treated with 
isoform-selective inhibitors of phosphatidylinositol 3′-kinases 
(PI3Ks). Inhibition of PI3Ks causes these cells to form pseudo-
pods that are multiple, weak, and transient, leading to the loss of 
persistent migration and impaired chemotaxis. We also show 
that PIP3 stabilizes polarity in two ways: fi  rst, by locally en-
hancing Rac activity to stabilize frontness at the leading edge; 
and second, by stimulating the activation of Cdc42, which pro-
motes RhoA-dependent backness at the trailing edge, thereby 
preventing the formation of multiple pseudopods.
Results
Effects of selective PI3K inhibition
To explore the roles of PIP3 in controlling polarity and che-
motaxis, we assessed the effects of compounds that inhibit 
different subsets of four class I PI3K isoforms expressed in 
dHL60 cells (Vanhaesebroeck et al., 1997; Naccache et al., 
2000;   Sawyer et al., 2003; and unpublished data). From a wide 
range of PI3K-inhibiting compounds, we chose fi  ve that show 
distinct patterns of isoform selectivity (Table S1, available at 
http://www.jcb.org/cgi/content/full/jcb.200604113/DC1) in vitro 
(Knight et al., 2004, 2006): IC87114 (selectively inhibits δ), 
TGX-115 (β and δ), PI-103 (α > β and δ), PIK-90 (α, γ, and δ), 
and PIK-93 (α and γ > δ). None of the fi  ve compounds is ex-
cluded from intact dHL60 cells (supplemental Results), and 
all are more potent and selective than classical PI3K inhibitors 
(Knight et al., 2006). Of these compounds, PIK-90 and -93 are 
unique in their potencies for inhibiting PI3Kγ in vitro (Table S1), 
for completely inhibiting the fMLP-stimulated phosphoryla-
tion of Akt, a kinase downstream of PIP3 (phosphorylated Akt 
[pAkt]; Fig. S1 and Table S2), for preventing the accumulation 
in pseudopods of the fl  uorescent PIP3 probe pleckstrin homol-
ogy domain (PH)–Akt-YFP (Fig. S2 A), and for impairing po-
larity and chemotaxis (Fig. 1). These results are consistent with 
observations (Hirsch et al., 2000; Li et al., 2000; Sasaki et al., 
2000) in PI3Kγ knockout mice. Consequently, we used these 
two inhibitors to effectively inhibit PI3Kγ, although contribu-
tions from other isoforms to these responses cannot be com-
pletely ruled out (supplemental Results).
Treatment of dHL60 cells with PIK-90 or -93 impairs con-
solidation and stability of the leading edge formed after treat-
ment with uniform fMLP, whereas the other three compounds 
do not (Fig. 1). None of the compounds signifi  cantly reduces 
the fMLP-dependent accumulation of total F-actin (Fig. S2 B), 
but PI3Kγ inhibition by treatment with PIK-90 or -93 alters its 
localization, as shown by the multiple pseudopods in Fig. 1 A. 
  Multiple F-actin–containing pseudopods are twice as frequent 
in PIK-90– or -93–treated cells 3 min after exposure to uniform 
fMLP relative to control cells or cells treated with the three 
other compounds (Table S3, available at http://www.jcb.org/
cgi/content/full/jcb.200604113/DC1). Time-lapse microscopy 
(Fig. 1 B) revealed that PIK-90 treatment destabilizes pseu-
dopods of living cells exposed to uniform fMLP. Control cells 
Figure 1.  Effects of PI3K inhibitors on polarity and chemotaxis. (A) Cellular 
distribution of F-actin. Cells in suspension were exposed for 40 min either 
to no drugs, to 10 μM IC87114 or TGX-115, or to 1 μM PI-103, PIK-90, 
and PIK-93, allowed to stick to coverslips for 15 min, and treated with 
100 nM fMLP for 3 min before ﬁ  xation and staining for F-actin (red), as 
  described in Materials and methods. Fluorescent and differential interfer-
ence contrast images are merged. (Note that fMLP induced the formation 
of more than one leading edge in the individual cells shown for PIK-90 
and -93, but this effect was not seen in all cells; see Results and Table S3) 
Bar, 10 μm. (B) Outlines of cells responding to stimulation with a uniform 
concentration of 100 nM fMLP. Cells were treated with or without 1 μM 
PIK-90 before treatment with fMLP. Each set of outlines represents a single 
cell observed at 1-min intervals (denoted by colors as indicated) after 
  exposure to fMLP. Each small circle represents the center of a protruding 
lamellum at the periphery of each cell at the indicated time. Outlines on the 
left or right represent three control (Ctr) or three PIK-90–treated cells, 
  respectively. Time-lapse videos of representative control or PIK-90–treated 
cells are shown in the supplemental material (Videos 1 and 2,   respectively). 
(C) CI (left) and turning frequency of cells treated with the compounds indi-
cated. Each bar represents the mean + one SEM (error bars) of different 
numbers of cells that were tested in multiple experiments: 30 control cells 
and 20, 10, 10, 29, and 18 cells for the compounds IC87114, TGX-115, 
PI-103, PIK-90, and PIK-93, respectively; concentrations of the same com-
pounds were 10, 10, 0.5, 0.5, and 0.5 μm, respectively. Asterisks indi-
cate that the value for cells treated with the compound differs from the 
corresponding control by P < 0.001. Trajectories of chemotaxing cells 
treated with two of these inhibitors are shown in Fig. S2 C (available at 
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(Fig. 1 B, left) typically polarize, form a single pseudopod, and 
crawl effi  ciently in one direction for several minutes; in con-
trast, the leading edges of PIK-90–treated cells (Fig. 1 B, right) 
persist for a short time (1–2 min) and retract, to be replaced by 
a leading edge at another site (Videos 1 and 2). Consequently, 
unlike control cells stimulated with uniform fMLP, PIK-90–
treated cells fail to migrate persistently in one direction.
In fMLP gradients, PIK-90 and -93 substantially reduce 
the chemotactic index (CI; the ratio of a cell’s displacement in 
the correct direction to the actual length of its migration path), 
whereas inhibitors selective for other PI3K isoforms do not 
(Fig. 1 C). In addition, PI3Kγ inhibition by either PIK-90 or -93 
triples the cells’ turning frequency, but the other three inhibitors 
have no effect (Fig. 1 C). PIK-90–treated cells migrate in jerky 
trajectories that are marked by frequent turns and less persistent 
orientation toward the source of attractant, which is in contrast to 
the straighter paths of control cells or cells treated with IC87114 
(Fig. S2 C). Nonetheless, the PIK-90–treated cells interpret the 
fMLP gradient correctly in that their wavering trajectories ac-
complish net migration in the up-gradient   direction (Fig. S2 C).
These results differ from our previous observations (Wang 
et al., 2002) with LY294002 or wortmannin in that dHL60 cells 
treated with either of these nonselective PI3K inhibitors showed 
poorly developed pseudopods and moved hardly at all (Wang 
et al., 2002). We suspect that this difference refl  ects the reported 
inhibition by the two nonselective agents of lipid and protein 
kinases that are distinct from PI3Ks (supplemental Results; 
Knight et al., 2006).
Frontness signals
Using pull-down assays or immunoblots of extracts of fMLP-
treated cells (Fig. 2), we asked how frontness signals are af-
fected by PIK-90 and latrunculin B (LatB), a toxin that blocks 
the formation of actin polymers by sequestering monomeric 
actin (Spector et al., 1983). LatB strongly reduces the fMLP-
  dependent accumulation of Rac-GTP and modestly reduces 
activation of the Rac- and Cdc42-dependent kinase p21-
  activated kinase (PAK), which is assessed by the accumula-
tion of   phosphorylated PAK (pPAK). LatB modestly reduces 
fMLP-  dependent pAkt accumulation as described previously 
(Wang et al., 2002) but has no effect on the accumulation of 
Cdc42-GTP. These effects presumably refl  ect the interruption 
of   F-actin’s participation in the PIP3–Rac–F-actin–dependent 
feedback loop in pseudopods (Niggli, 2000; Wang et al., 2002; 
Weiner et al., 2002) and suggest that Cdc42 activation is not 
subject to that feedback. Note that Fig. 2 shows results at a sin-
gle time point (1 min); careful time course analysis showed that 
all four responses (Cdc42-GTP, Rac-GTP, pAkt, and pPAK) 
peak at 1 min in control cells and in cells treated with LatB or 
PIK-90 (not depicted).
Effects of PIK-90 (Fig. 2) show a different pattern: the 
complete inhibition of fMLP-dependent pAkt and Cdc42-GTP 
accumulation, modest inhibition of pPAK accumulation, and 
severe inhibition of Rac activation. We suspect that the small 
residual Rac activation seen in PIK-90–treated cells suffi  ces to 
account for the fMLP-dependent elevation of normal amounts 
of F-actin (Fig. S2 B) and the formation of transient but multi-
ple fMLP-stimulated pseudopods (Fig. 1, A and B; and Table S3). 
In keeping with this idea, the expression of the dominant-
  negative Rac mutant (Rac-N17) inhibits pseudopod formation 
in PIK-90–treated cells (Fig. 3 A). This result, of course, does 
not completely rule out a Rac-independent contribution to 
pseudopod formation because the Rac mutant could affect 
mechanisms that are distinct from the activation of endogenous 
Rac. Consistent with the observed modest inhibition of pPAK, 
the p21-binding domain (PBD) of PAK fused to CFP (PAK-
PBD-CFP) still translocates to the periphery of PIK-90–treated 
cells that are treated with fMLP (Fig. 3 B). This probe was 
shown previously to refl  ect the localization of activated Rac in 
dHL60 (Srinivasan et al., 2003). Fig. 3 B shows that fMLP 
stimulates translocation of PAK-PBD-CFP to the entire cell 
  periphery at 1 min of PIK-90–treated cells, whereas at 3 min, 
the probe accumulates at multiple sites, which correspond to 
multiple leading edges. The same is true of cells in which 
Figure 2.  Effects of PIK-90 and LatB on the fMLP-stimulated 
activities of Rac and Cdc42 and the phosphorylation of Akt and 
PAK.  Cells received no pretreatment or were exposed for 
40 min to 40 μg/ml LatB, 0.5 μM PIK-90, or both and were 
stimulated with 100 nM fMLP for 1 min as indicated.  Incubations 
were terminated, and lysates were prepared as indicated in 
Materials and methods. Rac-GTP (isoforms 1 and 2) and 
Cdc42-GTP were assessed by a GST-PAK-PBD pull-down assay; 
total Rac, pAkt, and pPAK were measured by immunoblotting 
aliquots of the lysate used for the pull-down reaction (see 
  Materials and methods). The left panel shows representative 
blots for each condition. The right panel shows quantiﬁ  cation 
of the immunoblots, which were measured with the Image 
program (Scion). The y axis represents immunoblot intensities 
(arbitrary scales). For each immunoblot, the background signal 
was subtracted and all values were normalized: for Cdc42-
GTP and Rac-GTP, values were normalized to the signal (=1.0) 
detected in the absence of fMLP or inhibitor; and for pAkt and 
pPAK, values were normalized to the fMLP-dependent signal 
(=1.0) detected in the absence of inhibitor. Each graph repre-
sents the mean of three independent experiments, with different 
symbols representing the three actual values. Total Cdc42 and 
Rac in these extracts, which were not affected by PIK-90 or LatB, 
were used to check for equal loading in the different lanes.JCB • VOLUME 174 • NUMBER 3 • 2006  440
Cdc42 signals downstream of Cdc42-GTP are inhibited by the 
expression of ∆C-WASp.
Combined treatment with PIK-90 and LatB reduces the 
activation of both Rac and PAK to virtually nil (Fig. 2).  Compared 
with the effects of the two treatments alone, the reduction of 
pPAK accumulation caused by the combination of inhibitors is 
very much greater, suggesting that separate pathways dependent 
on PIP3 and F-actin normally converge to stimulate the maximal 
activation of PAK. With respect to the accumulation of Rac-GTP, 
each treatment substantially reduces the fMLP response, but the 
two together appear to induce even greater inhibition.
PI3K𝗄 inhibition, Cdc42, and RhoA activity
fMLP promotes RhoA activation by a pathway that requires 
PIP3 and the activation of Cdc42 (Fig. 4). fMLP treatment of 
intact neutrophils induces RhoA to associate with the particu-
late fraction of extracts from these cells (Niggli, 2003); PIK-90 
treatment reduces the basal RhoA content of particulate frac-
tions and prevents the response to fMLP (Fig. 4 A). The same 
effects are seen with a second assay (Fig. 4 B) that is based on 
the quantitative assessment of fl  uorescence resonance energy 
transfer (FRET) signals triggered by GTP occupying the gua-
nine nucleotide-binding pocket of a recombinant RhoA biosensor 
(Pertz et al., 2006). As we previously reported (Wong et al., 
2006), fMLP increases RhoA FRET in dHL60 cells. PIK-90 
lowers basal RhoA FRET and prevents fMLP from elevating it 
(Fig. 4 B). (For representative RhoA FRET images of individual 
cells corresponding to the averaged values shown in Fig. 4 [B–G], 
see Fig. S3; available at http://www.jcb.org/cgi/content/full/
jcb.200604113/DC1). In contrast, we previously reported (Xu 
et al., 2003) that LY294002 appeared to increase basal RhoA 
activity. This effect may refl  ect the documented (Knight et al., 
2006) effects of LY294002 on kinases other than PI3Ks 
(for further discussion, see supplemental Results).
PIK-90 treatment prevents the fMLP-dependent activation 
of Cdc42 (Fig. 2), and Cdc42-GTP mediates RhoA activation in 
response to fMLP (Fig. 4, C and D). Expression of a constitu-
tively active Cdc42 mutant, Cdc42-V12, signifi  cantly increases 
the mean RhoA FRET of cells that were not exposed to fMLP 
(Fig. 4 C). In addition, the expression of ∆C-WASp prevents 
fMLP from elevating the RhoA FRET signal (Fig. 4 D).
In addition to increasing RhoA activity (Fig. 4 C), Cdc42-
V12 in dHL60 cells prevents fMLP from inducing ruffl  ing and 
pseudopod formation, as previously described (Srinivasan et al., 
2003) and confi  rmed in Fig. 5. In retrospect, we overlooked the 
potential importance of this surprising Cdc42 effect, which differs 
strikingly from the Cdc42-stimulated formation of the fi  lopodia 
seen in fi  broblasts (Welch and Mullins, 2002). Now we fi  nd that 
Cdc42-V12 inhibits ruffl  ing and pseudopod formation because it 
induces the activation of a RhoA-dependent pathway that inhibits 
frontness responses. Indeed, morphologic effects of Cdc42-V12 
are reversed by treating cells with Y27632 to inhibit p160-ROCK 
(Fig. 5), a kinase that links RhoA to the phosphorylation of myo-
sin light chains and actomyosin contraction.   Although only 1/10 
Cdc42-V12–expressing cells made ruffl  es all around the cell at 
1 min and formed an F-actin–containing leading edge at 3 min in 
response to fMLP, 9/11 cells expressing the mutant protein did so 
after exposure to Y27632 (unpublished data). The morphologic 
effect of constitutively active Cdc42 (Fig. 5) closely mimics the 
reported (Xu et al., 2003)   effect of constitutively active RhoA, 
which was also reversed by exposure to Y27632.
Inhibiting Cdc42 with ∆C-WASp has an effect opposite to 
that of Cdc42-V12; that is, like PIK-90 and -93, it reduces fMLP-
stimulated RhoA activity (Fig. 4 D). This inhibition of RhoA is 
paralleled by effects on fMLP-stimulated polarity and chemo-
taxis, which also resemble effects of the PI3K inhibitors. We re-
ported previously (Srinivasan et al., 2003) that dominant-negative 
Cdc42 (Cdc42-N17) or ∆C-WASp cause cells to form multiple 
transient pseudopods in response to fMLP (Fig. 3 B). In the course 
of this study, we repeated these experiments and obtained virtu-
ally identical results (unpublished data). In addition, Cdc42-N17–
expressing cells migrated toward an fMLP-containing micropipette 
in jerky trajectories marked by multiple turns (unpublished data); 
these trajectories closely resembled those of cells treated with 
PIK-90 (Fig. S2 C). We infer from these results that the fMLP-
dependent activation of Cdc42, like the accumulation of PIP3, 
normally stimulates backness signals.
Figure 3.  Effects of PIK-90 and Cdc42 inhibition on the localization of Rac 
activity in pseudopods. (A) Cellular distribution of F-actin in Rac-N17–
  expressing cells. Cells transiently coexpressing Rac-N17 and PAK-PBD-CFP 
were exposed for 40 min to no drugs or 1 μM PIK-90, allowed to stick to 
coverslips for 15 min, and treated with 100 nM fMLP for 3 min before ﬁ  xa-
tion and staining for F-actin, as described in Materials and methods. Each 
set of pictures shows one cell expressing the ﬂ  uorescent marker and one 
untransfected cell. (B) Cells expressing PAK-PBD-CFP pretreated in suspen-
sion with or without 1 μM PIK-90 for 40 min or cells coexpressing PAK-PBD-
CFP and ∆C-WASp were allowed to stick to a coverslip for 15 min and 
were exposed to a uniform concentration of 100 nM fMLP. Images show 
the time course of response of a single control, a PIK-90–treated cell, and 
a ∆C-WASp–expressing cell at the times indicated after the addition of 
fMLP. Arrows point to pseudopods. Bars, 10 μm.PIP3 AND CDC42 REGULATE RHOA • KEYMEULEN ET AL. 441
Because the loss of fMLP-dependent RhoA activation in 
PIK-90–treated cells is accompanied by the reduced activation 
of Rac (Fig. 2), we used Rac mutants to ask whether Rac-GTP 
plays a role in activating RhoA. Expression of a constitutively 
active Rac mutant, Rac-V12, failed to elevate RhoA biosensor 
activity in unstimulated cells (Fig. 4 E), and Rac-N17, a domi-
nant-negative mutant, did not inhibit the fMLP response (Fig. 4 F). 
These results are directly opposite to those seen with Cdc42-
V12 and ∆C-WASp, respectively. We infer that Rac activation 
is neither suffi  cient nor necessary for RhoA activation.
Finally, we reported (Xu et al., 2003) that G12 and G13, 
which are trimeric G proteins, mediate fMLP stimulation of 
backness based on observations with constitutively active and 
dominant inhibitory mutants of these proteins. In accord with 
these fi   ndings, the expression of dominant-negative G12/13 
prevents fMLP from activating the RhoA biosensor (Fig. 4 G). 
Because the multiple fMLP-dependent pseudopods of G12/13-
inhibited cells accumulate prominent PH-Akt-GFP fl  uorescence 
(Xu et al., 2003), they presumably also accumulate PIP3 and 
Cdc42-GTP in response to fMLP, although such responses 
could not be quantitated. Therefore, we suspect that RhoA acti-
vation requires simultaneous positive inputs from G12/13 and 
the long-range pathway triggered by PIP3/Cdc42, although a 
strong Cdc42 signal (from Cdc42-V12) can override the 
 requirement for G12/13. Cdc42 may also activate RhoA through 
G12/13 independently of the receptor, as suggested by the 
Figure 4.  RhoA activation depends on PI3K𝗄 and Cdc42. (A) fMLP-  induced 
membrane association of RhoA. Cells received no pretreatment or were 
exposed for 40 min to 0.5 or 1 μM of PIK-90 as indicated and were stimu-
lated with or without 100 nM fMLP for 1 min as indicated. RhoA that asso-
ciated with the particulate fraction of cell extracts was then assessed as 
described in Materials and methods. The top and bottom panels show a 
representative immunoblot and quantiﬁ   cation of immunoblotted bands 
measured with the Image program (Scion), respectively. For each immuno-
blot, the background signal was subtracted, and the level of RhoA was 
normalized to that of transferrin in the particulate fraction; all values were 
further normalized to the signal detected in the absence of inhibitor, which 
was set at 1.0. Each graph represents the mean of three independent 
  experiments, with different symbols representing the three actual values. 
(B–G) Quantiﬁ  cation of mean FRET/CFP ratios in cells treated under differ-
ent conditions. Data were obtained from n ≥ 25, 14, 18, 12, 13, or 13 
cells in B–G, respectively, and were normalized to the FRET/CFP signal 
measured in unstimulated control cells. Similar results were observed in 
three independent experiments. Error bars indicate one SEM. t tests were 
performed to compare data of unstimulated control versus other experimen-
tal groups and between stimulated control and other conditions. Pairs of 
treatments that showed a statistically signiﬁ  cant difference are marked with 
asterisks (*, P ≤ 0.05; **, P ≤ 0.001 by t test). (B) Lentivirus-transformed 
cells expressing the RhoA biosensor were treated with or without 1 μM 
PIK-90 for 40 min, stimulated with 100 nM fMLP for 3 min as indicated, 
ﬁ  xed, and subjected to FRET imaging. (C–G). dHL60 cells transiently trans-
fected with the RhoA biosensor and Cdc42-V12, ∆C-WASp, Rac-V12, 
Rac-N17, or G12/G12-DN, as indicated, were stimulated with 100 nM 
fMLP for 3 min as indicated.
Figure 5.  Treatment with the ROCK inhibitor Y27632 partially rescues 
the Cdc42-V12 phenotype. Cells were transiently transfected with YFP-
  actin alone (control) or YFP-actin plus Cdc42-V12. After 4 h, cells were 
  allowed to adhere to the coverslip in the presence of 10 μM Y27632 
(for 20 min). Differential interference contrast and the corresponding 
  ﬂ  uorescent images are shown. Cells were then uniformly stimulated with 
100 nM fMLP. Time after fMLP addition is indicated. Arrows point to 
  pseudopods. Bar, 10 μm.JCB • VOLUME 174 • NUMBER 3 • 2006  442
  increased basal RhoA activity in cells overexpressing a consti-
tutively active Cdc42 in the absence of fMLP.
Discussion
Stabilizing broken symmetry
We proposed (Xu et al., 2003; Wong et al., 2006) that dHL60 
cells polarize and break their symmetry when fMLP stimulates 
competing Gi-dependent frontness and G12/13-dependent 
backness responses whose mutual incompatibility causes them 
to segregate into separate membrane regions. However, breaking 
symmetry is not enough. Cells treated with PIK-90 or -93 break 
their symmetry in response to fMLP quite easily but do not 
maintain a single persistent pseudopod and a single persistent 
back; consequently, they cannot migrate persistently in one 
  direction in uniform fMLP or migrate effi  ciently up fMLP gra-
dients (Fig. 1). Intuitively, we might have suspected that com-
peting frontness and backness responses alone would not suffi  ce 
to maintain stable polarity. Responses of approximately equal 
strengths would probably produce a shifting array of multiple 
transient fronts and backs, whereas the excess strength of one 
response might easily enable it to win the competition. For in-
stance, positive feedback loops between frontness signals could 
generate pseudopods covering the entire cell surface.
How, then, do neutrophils maintain stable polarity? Our ex-
periments indicate that PIP3 and Cdc42, which were generated as 
part of the frontness response, exert a powerful stabilizing effect 
by strengthening pseudopods and by promoting long-range acti-
vation of Rho-dependent backness (Figs. 2 and 4). Inhibiting 
PI3Kγ or Cdc42 activity disrupts this stabilizing effect, leading to 
the formation of multiple transient pseudopods. Normally, how-
ever, PIP3 and Cdc42 signals originating in a strong pseudopod 
effectively promote G12/13- and RhoA-dependent actomyosin-
based contractility at the cell’s opposite end, and the proportion-
ately stronger back increases the likelihood of achieving stable 
asymmetry with a single robust pseudopod and one back.
This scenario resembles local excitation global inhibition 
models (Meinhardt, 1999; Devreotes and Janetopoulos, 2003), 
which combine local positive feedback and a globally active 
diffusible inhibitor. For amoebae of D. discoideum, the local 
excitation global inhibition model (Devreotes and  Janetopoulos, 
2003; Janetopoulos et al., 2004) proposes that PIP3 at the front 
promotes actin polymerization with positive feedback, whereas 
an unidentifi  ed signal generates a rapidly diffusible mediator 
that activates phosphatase and tensin homologue (PTEN), a 
PIP3 phosphatase, at the back of the cell.
The Rho pathway is reported to enhance PTEN localiza-
tion at the trailing edge of mouse neutrophils (Li et al., 2005). 
However, this effect is probably not essential for stabilizing 
neutrophil polarity because we (Xu et al., 2003) and others 
(  Lacalle et al., 2004) could not detect PTEN localization to the 
trailing edge of dHL60 cells, and neither excess nor the deple-
tion of PTEN altered gradient sensing (Lacalle et al., 2004).
Long-range effects of PIP3 and Cdc42
Just as actomyosin contraction constrains the pseudopod to 
a single location (Xu et al., 2003), local effects of protrusive 
F-actin at the front of the cell reciprocally inhibit RhoA activa-
tion and actomyosin-based contraction (Wong et al., 2006). 
How do PIP3 and Cdc42, which are generated at the leading 
edge, exert long-range positive regulation of RhoA outside 
pseudopods (Fig. 5)?
Long-range regulation involving PIP3 or Cdc42 has been 
described in other systems, but mechanisms are poorly under-
stood. One precedent is the sharp segregation of Cdc42-GTP 
and RhoA-GTP into spatially separated concentric rings that 
surround and promote the closure of plasma membrane wounds 
in frog oocytes (Benink and Bement, 2005). Active Cdc42 in 
this system is physically separate from active RhoA but is none-
theless required for RhoA to become active. A second prec-
edent is the ability of PIP3 at the leading edge of D. discoideum 
amoebae to trigger a kinase cascade that promotes myosin II 
contraction at the back (Chung et al., 2001). Instead of Cdc42 
and Rho, the D. discoideum pathway depends on the PIP3-
  dependent activation of Akt/PKB and subsequent activation of 
PAKα, a PAK1 homologue located at the back of the cell. How 
the message moves from Akt/PKB at the front to PAKα at the 
back is unknown.
One possibility in dHL60 cells is that PIP3 and Cdc42 lead 
to the generation of a phosphorylated protein or a cytosolic sec-
ond messenger that diffuses rapidly from the front to the back. 
The putative diffusible mediator could augment activation of a 
Rho guanine nucleotide exchange factor or inhibit activity of 
a GTPase-activating protein that inactivates Rho.   Alternatively, 
Cdc42 could also promote transport of a regulator from front 
to back via endocytosed vesicles and microtubules. A possible 
role for microtubules is consistent with the documented ability 
of Cdc42 to regulate the interaction of microtubules with the 
cell cortex (Wittmann and Waterman-Storer, 2001;   Gundersen, 
2002), with microtubule-dependent delivery of a Rho gua-
nine nucleotide exchange factor to the plasma membrane of 
  Drosophila melanogaster S2 cells (Rogers et al., 2004), and 
with microtubule-dependent localization of RhoA activity at the 
cleavage plane of frog oocytes (Bement et al., 2005).
Cdc42 has been reported to regulate actomyosin contrac-
tion via myotonic dystrophy kinase-related Cdc42-binding kinase 
independently of ROCK (Wilkinson et al., 2005). Such a role for 
myotonic dystrophy kinase-related Cdc42-binding kinase is un-
likely to be quantitatively important in fMLP-treated dHL60 cells 
because inhibiting ROCK with Y27632 rescues the inability of 
Cdc42-V12–expressing cells to form pseudopods (Fig. 5).
PIP3, Rac, and Cdc42 cooperate 
at the leading edge
Why are pseudopods of PIK-90–treated cells weak and tran-
sient (Fig. 1) despite the accumulation of quantitatively normal 
amounts of F-actin (Fig. S2 B)? The most likely explanation is 
that reduced PIP3 accumulation dramatically reduces the acti-
vation of Rac (Fig. 2), an essential positive regulator of actin 
polymerization. Our results also suggest that the loss of PIP3 
inhibits the consolidation of Rac activity into one region of the 
cell periphery so that the remaining active Rac, which is de-
tected by the localization of PAK-PBD-CFP, localizes in multi-
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Maintaining strong pseudopods may require positive PIP3-
dependent signals mediated by Cd42 as well as Rac.   Indeed, the 
pseudopod defects of cells exposed to PIK-90 and -93 inhibitors 
(Fig. 1) closely resemble those of cells expressing inhibitors of 
Cdc42 (Srinivasan et al., 2003): in both cases, pseudopods are 
not only multiple but are also transient and weak. One potential 
integrator of Rac and Cdc42 signals in pseudopods is PAK1, 
which can be activated by both GTPases, phosphorylates nu-
merous cytoskeletal regulators, and promotes the formation of 
protrusive actin with the inhibition of contractile actomyosin 
(Bokoch, 2003). In favor of this possibility, PAK1 in dHL60 
cells appears to be regulated by a PIP3-  dependent signal in ad-
dition to an F-actin–dependent positive feedback signal; either 
PIK-90 or LatB treatment alone only inhibits a portion of the 
pPAK response, but inhibiting both signals blocks the response 
almost completely (Fig. 2). Finally, it is also possible that Cdc42 
augments pseudopod strength and stability by stimulating actin 
polymerization directly via   Wiskott-Aldrich   Syndrome proteins 
(Welch and Mullins, 2002).
Conclusions
We have shown that PIP3 and Cdc42 in dHL60 cells stabilize 
polarity in two ways: by making pseudopods more robust and 
also by augmenting Rho-dependent actomyosin contraction at 
the trailing edge. Although initiated by signals generated at the 
front of the cell, the latter effect is manifested at the back of the 
cell as an augmentation of the fMLP- and G12/13-dependent 
activation of RhoA. This long-range activation of RhoA and the 
resulting actomyosin contraction serve to inhibit the formation 
of protrusive pseudopods, thereby maintaining robust polarity 
with a single pseudopod and a single back.
The present fi  ndings should stimulate further investiga-
tion in at least three directions. First, we need to understand the 
molecular mechanisms that connect Cdc42 to RhoA across the 
cell’s diameter. Second, because inhibiting PIP3 accumulation 
and Cdc42 activation impairs but does not completely abolish 
dHL60 polarity and chemotaxis, polarity is probably supported 
by additional long-range interactions between signals generated 
at the front or back and reinforcing polarity responses at the op-
posite side of the cell. Finally, intuition must be converted into 
a model that quantitatively predicts the effects of perturbing 
specifi  c signals on the initiation and stability of polarity.
Materials and methods
Materials
Antibodies against Akt, phosphorylated at T308 (pAkt) and PAK and phos-
phorylated at S199/204 (pPAK), were obtained from Cell Signaling 
  Technology. Mouse monoclonal antibody against RhoA was purchased 
from Santa Cruz Biotechnology, Inc. Mouse antitransferrin receptor anti-
body was purchased from Zymed Laboratories. LatB and Y27632 were 
obtained from Calbiochem, and GST-PAK-PBD and antibodies against Rac 
(isoforms 1 and 2) were purchased from Pierce Chemical Co. Rhodamine-
phalloidin was obtained from Invitrogen, and human ﬁ  bronectin was ob-
tained from BD Biosciences. Protease and phosphatase inhibitor cocktails 
and fMLP were obtained from Sigma-Aldrich. HRP-conjugated donkey 
anti–rabbit and anti–mouse IgG were purchased from GE Healthcare. 
Glass capillaries obtained from Frederick Haer Co. were converted into 
micropipettes with a puller (P-87; Sutter Instrument Co.). Compounds 
IC87114, TGX-115, PI-103, and PIK-93 were dissolved in DMSO; PIK-90 
was dissolved in 50:50 DMSO/H2O; all compounds were stored at 
−20°C. Final   dilutions were performed in cell media, with a ﬁ  nal DMSO 
dilution of 0.5% for PIK-90 and 1.0% for the other compounds.
DNA constructs and lentiviral expression
Myc-tagged V12-Cdc42 cloned in pTET7 was described previously 
  (Kalman et al., 1999a); to activate its expression, this construct was co-
transfected with a plasmid constitutively expressing a tetracycline repres-
sor VP16 fusion protein, as also described previously (Srinivasan et al., 
2003). Myc-tagged Rac-V12 and Rac-N17 were purchased from the 
  Guthrie cDNA Resource Center. ∆C-WASp (Kalman et al., 1999b) and 
PAK-PBD-CFP (Kraynov et al., 2000) were described previously. The RhoA 
biosensor construct used for transient transfection was described previ-
ously (Pertz et al., 2006). Quasi-stable expression of the RhoA biosensor 
or PH-Akt-YFP was accomplished by lentiviral transfection as described 
previously (Wong et al., 2006). G12- and G13-DN constructs (residues 
326–379 for Gα12 and residues 321–377 for Gα13) were gifts from 
Y. Takuwa (Kanazawa University, Kanazawa, Japan) and were described 
previously (Sugimoto et al., 2003). Transient transfection with the RhoA 
  biosensor, Cdc42-V12, ∆C-WASp, Rac-V12, Rac-N17, or G12/G13-DN 
was previously described (Srinivasan et al., 2003); experiments were per-
formed 4 h after transfection.
Cell culture
Procedures for cultivation and DMSO-stimulated differentiation of HL60 
cells have been previously described (Servant et al., 2000).
Microscopic analysis
Live dHL60 cells were imaged in 1.5% human albumin in modiﬁ  ed HBSS 
(mHBSS) at room temperature using an inverted microscope (Eclipse TE200; 
Nikon) equipped with a Photometrics cooled CCD camera (CE300; Roper 
Scientiﬁ   c) driven by DeltaVision software (Applied Precision). Pictures 
shown were taken with a 60× NA 1.40 oil planApo objective (Nikon), 
whereas tracking experiments were performed with a 20× NA 0.75 pla-
nApo objective (Nikon). Cell trajectories were tracked using SoftWorx soft-
ware (Applied Precision). The CI was calculated as described previously 
(Xu et al., 2005): CI = (AO − BO)/AB, where O is the position of the mi-
cropipette; A and B are the cell’s position at time = 0 and time = 25 min, 
respectively; AO is the distance from A to O; BO is the distance from B to 
O; and AB is the actual length of the cell’s curving migration path from 
HL60 A to B. Turns in a cell trajectory were quantiﬁ  ed by approximating the 
cell’s trajectory over successive 2-min intervals, with a vector derived from 
a least squares deviation ﬁ  t to ﬁ  ve successive positions of the leading edge 
(coordinates are assessed at 30-s intervals).   Angles between each succes-
sive pair of vectors were computed; a turn was deﬁ  ned as a deviation of 
one 2-min vector from its predecessor by 60° or more in either direction.
Actin staining
dHL60 cells were preincubated in suspension with IC87114, TGX-115, 
PI-103, PIK-90, PIK-93, or no treatment for 40 min, centrifuged for 5 min 
at 2,000 rpm at room temperature in a J6-B centrifuge (Beckman Coulter), 
resuspended in mHBSS containing the respective agent at the same con-
centration, allowed to stick to ﬁ   bronectin-covered coverslips, and sub-
jected to stimulation with a uniform concentration of 100 nM fMLP for 
3 min. Cells were ﬁ   xed in 3.7% PFA and stained with 10 units/ml 
  rhodamine-phalloidin for 15 min.
Pull-down assay for activated Cdc42 and Rac
dHL60 cells were preincubated for 40 min with 40 μg/ml LatB, 0.5 μM 
PIK-90, or both, centrifuged for 5 min at 2,000 rpm at room temperature 
in a J6-B centrifuge (Beckman Coulter), resuspended in mHBSS (2 × 10
7 
cells in 0.5 ml per condition), and stimulated or unstimulated for 1 min with 
100 nM fMLP. The reaction was stopped by adding 0.5 ml of 2× lysis buf-
fer at 4°C (1× lysis buffer: 25 mM Tris-HCl, pH 7.5, 150 mM NaCl, 5 mM 
MgCl2, 1% NP-40, 1 mM DTT, and 5% glycerol, protease inhibitor, and 
phosphatase inhibitor cocktails). Subsequent steps were performed as 
  described in the protocol attached to the Cdc42 and Rac pull-down kit 
(Pierce Chemical Co.).
Assay for particulate-associated RhoA
dHL60 cells with or without 40 min of pretreatment with 0.5 or 1 μM 
PIK-90 were stimulated for 0 or 1 min with 100 nM fMLP. Particulate frac-
tions were prepared as described previously (Xu et al., 2005). The level of 
RhoA in the particulate fraction was normalized to that of the transferrin 
  receptor. This assay was ﬁ  rst described by Niggli (2003). For comparison, 
the normalized data were further standardized by setting the unstimulated 
control value to one.JCB • VOLUME 174 • NUMBER 3 • 2006  444
FRET analysis
Cells quasi-stably expressing the RhoA biosensor were pretreated with or 
without 1 μM PIK-90 for 40 min, resuspended in 1.5% human albumin in 
mHBSS, and plated on ﬁ  bronectin-coated coverslips before treatment with or 
without 100 nM fMLP for 3 min. Cells transiently cotransfected with the RhoA 
biosensor and Cdc42-V12, ∆C-WASp, Rac-V12-myc, Rac-N17-myc, or G12 
and G13 dominant-negative mutants were subjected to the same procedure 
without exposure to PIK-90. Images were acquired at room temperature, and 
data were processed as described previously (Wong et al., 2006).
Online supplemental material
Supplemental material provides details about the selectivity of PI3K in-
hibitors and methods for the F-actin. Table S1 provides IC50 values for 
inhibiting class I PI3K isoforms in vitro. Table S2 provides IC50 values 
of ﬁ  ve compounds for inhibiting pAkt accumulation in dHL60 cells. Table 
S3 provides data on how PI3Kγ inhibitors induce cells to form multiple 
leading edges in response to fMLP. Fig. S1 shows the effects of ﬁ  ve PI3K 
inhibitors on the phosphorylation of Akt in dHL60 cells. Fig. S2 shows the 
effects of inhibiting PI3Kγ on PIP3 localization, accumulation of F-actin, 
and chemotaxis. Fig. S3 shows the subcellular distribution of the FRET 
signal. Video 1 shows YFP-actin–expressing cells in uniform stimulation, 
and Video 2 shows PIK-90–treated YFP-actin–expressing cells in uniform 
stimulation. Online supplemental material is available at http://www.jcb.
org/cgi/content/full/jcb.200604113/DC1.
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